Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cureus|November 29, 2023
The Prevalence and Patterns of Toxicity With Immune Checkpoint Inhibitors in Solid Tumors: A Real-World Experience From a Tertiary Care Center in OmanBushra Salman, Nameer M AlWard, Zamzam Al-Hashami, et al.Oman Medical Journal|May 22, 2019
Gestational Trophoblastic Disease at Sultan Qaboos University Hospital: Prevalence, Risk Factors, Histological Features, Sonographic Findings, and OutcomesNihal Al Riyami, Marwa Al Riyami, Al Thuriya Al Hajri, et al.Frontiers in Immunology|July 16, 2026
Successful management of pembrolizumab-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in a patient with uterine serous carcinoma: a case reportTasabeeh Hamad, Ana Maria Serrano, Shaher Al Kaabi, et al.Hematology/Oncology and Stem Cell Therapy|April 15, 2017
Therapeutic drug monitoring-guided dosing of busulfan differs from weight-based dosing in hematopoietic stem cell transplant patientsBushra Salman, Mohammed Al-Za'abi, Mohammed Al-Huneini, et al.Sultan Qaboos University Medical Journal|June 28, 2023
Predictors of Hypersensitivity Reactions to Platinum-Based Chemotherapy in a Tertiary Care Hospital in Oman: A case control studyBushra Salman, Fatma Al-Rasbi, Nameer Al-Ward, et al.Current Oncology (Toronto, Ont.)|April 27, 2026
Association of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) Scores with Guideline Recommendations in Breast CancerBushra Salman, Intissar Yehia, Hadil Al Sharqi, et al.Health Economics Review|July 15, 2026
Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approachSaid Wani, Hilal Alsabti, Said Allamki, et al.Journal of Pharmaceutical Policy and Practice|December 12, 2025
Methodological guidelines for Health Technology Assessment in OmanSaid Wani, Hilal Alsabti, Said Allamki, et al.Pageof 2